✦ LIBER ✦

Intraperitoneal therapy with interleukin-2 (nIL-2) in patients with ovarian carcinoma — Pre-clinical and clinical results

✍ Scribed by W Schröder; R Lissner; HC Bender

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of intraperitoneal recom

✍ Paul B. Chapman; Jonathan E. Kolitz; Thomas B. Hakes; Janice L. Gabrilove; Karl 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 731 KB

Interleukin-2 dose, blood monocyte and C

✍ Gregers G. Hermann; Poul F. Geertsen; Hans von der Maase; Jesper Zeuthen 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 583 KB

Clinical effects and toxicity of interle

✍ Michael T. Lotze; Yvedt L. Matory; Anthony A. Rayner; Stephen E. Ettinghausen; J 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 938 KB

Intraperitoneal chemotherapy versus no t

✍ Joseph Menczer; Gilad Ben-Baruch; Shulamit Rizel; Harry Brenner 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 2 views

Polyethylene glycol conjugated interleuk

✍ Ronald M. Bukowski; James Young; Gary Goodman; Frederick Meyers; Brian F. Issell 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 487 KB

Correlation between clinical response to

✍ Bain, C; Merrouche, Y; Puisieux, I; Blay, J-Y; Negrier, S; Bonadona, V; Lasset, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 555 KB